FT Global Pharmaceuticals and Biotechnology Conference 2013
 
Who Should Attend?  

The FT Pharmaceutical & Biotechnology Conference attracts senior level executives and corporate decision-makers from around the world including Chairmen, CEOs, CFOs, Presidents and Managing Directors from:
  • Pharmaceutical and biotechnology companies
  • Medical devices, medical technology, instrumentation and diagnostics companies
  • Health insurers, government and private health service providers
  • Regulatory agencies and health technology assessment bodies
  • Investment banks,private equity,venture capital, pension and IP funds
  • Patient representative organisations, health NGOs and social media consultancies




2012 Conference Attendees Included:

Abbott
Abingworth Management LLP
Accelrys
ACES Health Care
Actavis EAD
Addex Pharmaceuticals
AGales Consulting Ltd
Amgen
Association of the British Pharmaceutical Industry
Astellas Pharma Europe Limited
AstraZeneca
Bain & Company
Bank of America Merrill Lynch
Bank of Tokyo-Mitsubishi UFJ
Barclays Capital
Bayer Pharma AG
Bio City Development Company
Brazilian Development Bank
CardioMEMS
Celgene
Cellca GmbH
Center for Health and Medical Research
Centerview Partners UK LLP
Clinuvel AG
Consort Medical plc
Decision Resources International
Deloitte
Deloitte & Touche LLP
Deloitte Conseil
Deloitte Financial Advisory Services
Deloitte MCS Limited
Dottikon Exclusive Synthesis
Double Helix Consulting
Elan Pharma International Ltd
Ernst & Young LLP
F. Hoffmann-La Roche AG
Fasken Martineau LLP
FIZ Frankfurt Biotechnology Innovation Centre
Fund Assist Ltd


GE Healthcare UK Ltd
GENFITGenzyme Therapeutics
GSK
H. Lundbeck A/S
Harpum ConsultingHay Group
Helvoet Pharma Belgium NV
Hill & Knowlton Hoffmann Neopac AG
HP Life Sciences
Hungarian Investment and Trade Agency
IDA Ireland
MS Health SpaIntercell
USAInvest KL
Janssen EMEA
Janssen Healthcare Innovation
Johnson & Johnson
JP Morgan
JT International S.A.
Kloeckner Pentaplast Group
KPMG
KPMG AG
KPMG LLP
Landesbank Berlin AG
LEK Consulting
LG Life Sciences, Ltd.
London Business School
Lundbeck Italia
McKinsey & Company
Medco International
Medinova AG
Mediq NVMedtronic
Menarini Biotech
Merck Serono
Mobile Worldwide
Monitor
MSD
MYLAN
National Health Research Institutes
Novaquest capital

Novartis
Novartis PharmaNovartis Pharmaceuticals UK Ltd
Novo Nordisk Limited
Nycomed: a Takeda Company
Paralax Life Sciences
Pfizer
Pfizer Turkey
Pope Woodhead & Associates
ProDuCt
PwC
Quintiles
RAND Europe
RLM Finsbury 
Roche
RSA
Russell Reynolds Associates
Sandoz Ltd
Santaris Pharma A/S
SCA Cool Logistics
SEP
Societe Generale Corporate & Investment Banking
Spencer Stuart
STJ Advisors
Strategic Partners Group
Sumitomo Mitsui Banking Corporation
Takeda Pharmaceuticals Europe Ltd
The Boston Consulting Group
Tillotts Pharma AG
Tokai Pharmaceuticals
Torreya Partners LLP
UCD Smurfit School of Business
Vallee
Value Edge Research
Vifor Pharma UK Ltd
Vintura
Walter Scott & Partners
WCI Consulting Limited
WorldOne Research Ltd